Delivery Order SPE2DB24D3013-SPE2DB25FFPAQ
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $9,124.26 to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal sprays. This firm fixed-price contract, with an ultimate completion date of August 20, 2025, represents a competitive award with no set-aside designation. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. Valtoco is a rescue medication used for acute seizure management, reflecting the Department of Defense's ongoing...
- The Defense Logistics Agency awarded a delivery order valued at $6,726.02 to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal sprays, with an ultimate completion date of August 25, 2025. This firm fixed-price contract, awarded on August 22, 2025, was not set-aside and represents a competitively awarded delivery order. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. Valtoco is a critical emergency medication used primarily for acute seizure...
- The Defense Logistics Agency awarded a delivery order valued at $1,129.62 to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal sprays, with an ultimate completion date of August 12, 2025. This is a firm fixed price contract with no set-aside designation, competitively awarded on August 11, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Valtoco is a rescue medication used for acute repetitive seizure clusters in epilepsy...
- The Defense Logistics Agency awarded a delivery order valued at $4,107.10 to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal sprays, with an ultimate completion date of August 19, 2025. This is a firm fixed price delivery order with no set-aside designation, meaning it was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Valtoco is a rescue medication used to treat acute seizure clusters in epilepsy patients,...
- The Defense Logistics Agency awarded a delivery order valued at $1,688.89 to AmerisourceBergen Drug Corp for Valtoco 5 mg nasal sprays on August 13, 2025, with completion scheduled for August 14, 2025. This firm fixed-price delivery order, issued without set-aside designation, will be performed at the contractor's facility in Conshohocken, Pennsylvania. Valtoco is a rescue medication indicated for acute repetitive seizure episodes in patients with epilepsy, representing a critical specialty...
- The Defense Logistics Agency awarded a $1,129.62 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal sprays, with an ultimate completion date of August 8, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. The product will be performed at AmerisourceBergen's facility in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Valtoco 15 mg nasal sprays, valued at $3,771.10. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The contract is set to be completed by August 27, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Valtoco 10 mg nasal sprays, with a contract ceiling value of $1,203.35. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of August 5, 2025. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal sprays, valued at $3,388.86 under a firm fixed-price contract. This competitive award, made on September 9, 2025, with an ultimate completion date of September 10, 2025, represents a small-value transaction for a specialized pharmaceutical product. Valtoco is an emergency rescue medication used to treat acute seizures in patients with epilepsy. The contractor, headquartered in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Valtoco 10 mg nasal spray, a seizure rescue medication. This competitively awarded, firm fixed-price delivery order carries a ceiling value of $1,784.67 and is scheduled for completion by August 4, 2025. The contract represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and...
- SPE2DB24D3013Indefinite Delivery Contract
- SPE2DB24D3013-SPE2DB25FFPAQDelivery Order
This delivery order, awarded August 5, 2025, by the Defense Logistics Agency to AmerisourceBergen Drug Corp, provides Valtoco 10 mg nasal sprays with a ceiling value of $1,277.03 and an ultimate completion date of August 6, 2025. Valtoco is a rescue medication used for acute seizure management. The award was made on a firm fixed price basis without a set-aside designation, indicating competitive procurement. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The prime contract serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to military healthcare programs worldwide. DLA's Medical Supply Chain relies on AmerisourceBergen as a critical vendor for federal medical procurement needs supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's extensive contract portfolio demonstrates its capability to fulfill diverse medical supply requirements across multiple therapeutic domains through competitive procurement processes.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 8/5/25 |